xGen Acute Myeloid Leukemia Cancer Panel
CAT# PRODUCT SIZE STORAGE Һڰ ֹ
101630316 rxn xGen AML Cancer Panel v1.016 rxn-α
101630296 rxn xGen AML Cancer Panel v1.096 rxn-α

xGen Acute Myeloid Leukemia Cancer Panel

The xGen AML Cancer Panel v1.0 comprises 11,743 xGen Lockdown Probes, spanning 1.19 Mb of the human genome, for targeted enrichment of >260 genes associated with AML, to provide more efficient detection of disease-causing mutations.

  • Obtain high coverage uniformity with 98% of genomic targets covered at greater than 0.2 x mean coverage
  • Detect variations reliably with high reproducibility and increased depth of coverage
  • Observe high relevance for AML-related applications due to empirically derived targets
  • Enjoy fast turnaround via easy online ordering and next day shipping

xGen Acute Myeloid Leukemia Cancer Panel

Product

Pricing

16 rxn xGen AML Cancer Panel v1.0

₩4,500,000 KRW

96 rxn xGen AML Cancer Panel v1.0

₩15,300,000 KRW

 

The xGen Acute Myeloid Leukemia Cancer Panel v1.0 is comprised of individually synthesized and quality controlled xGen Lockdown Probes. The panel consists of 11,743 xGen Lockdown Probes targeting empirically derived regions within 260 genes. The targets were defined by whole genome and exome sequencing of 200 AML patients.

Panel composition (target genes)

Table 1. Frequently researched genes included in the xGen AML Cancer Panel.*

ASXL1

FAM154B

IDH2

KDR

NPM1

PRAMEF2

C17orf97

FAM47A

JAK1

KIT

NRAS

PTPN11

CBL

FAM5C

JAK2

KRAS

NTRK3

RUNX1

CEBPA

FLRT2

JAK3

LRRC4

OR13H1

TET2

DNMT3A

FLT3

KCNA4

MLL3

OR8B12

TP53

EGFR

GJB3

KCNK13

MYC

P2RY2

TUBA3C

EZH2

IDH1

KDM6A

NF1

PCDHB1

WT1

* The panel does not target every exon in each gene, but targets all regions found to be mutated in the TCGA study (N Engl J Med, 368(22):2059–2074). For a complete list of genes, click here.

 

ı
ıⰡ ϴ.
ı ۼ
gototop